Ekso Bionics Estimates Q4 Total Revenue Of $4.7M-$4.9M Vs. $3.6M Posted Last Year; FY23 Revenue Of $18.1M-$18.3M Vs. $12.9M In 2022
Portfolio Pulse from Benzinga Newsdesk
Ekso Bionics Holdings, Inc. has estimated its Q4 total revenue to be between $4.7M-$4.9M, a significant increase from the $3.6M reported in the same quarter last year. For the full year 2023, the company expects revenue to be between $18.1M-$18.3M, compared to $12.9M in 2022, indicating strong year-over-year growth.
January 04, 2024 | 10:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ekso Bionics Holdings, Inc. is expected to report a strong increase in Q4 revenue and a substantial rise in annual revenue for FY23, indicating a positive growth trajectory.
The projected increase in both Q4 and annual revenue for Ekso Bionics suggests that the company is experiencing significant growth. This positive financial news is likely to be well-received by investors and could lead to a short-term increase in the stock price, as revenue growth is a key indicator of a company's performance and future potential.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100